The "fate" of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood-brain barrier crossing and trafficking into the central nervous system

Journal of Drug Delivery Science and Technology

Volumn 32, Issue , 2016, Pages 66-76

  Tosi, Giovanni ^a   Musumeci, Teresa ^b   Ruozi, Barbara ^a   Carbone, Claudia ^b   Belletti, Daniela ^a   Pignatello, Rosario ^b   Vandelli, Maria Angela ^a   Puglisi, Giovanni ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Blood brain barrier; Brain; Brain tumors; Central nervous system; Nanomedicine; Polymeric nanoparticles; Solid lipid nanoparticles

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOSOME; NANOCARRIER; POLYMER; SOLID LIPID NANOPARTICLE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN TUMOR; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; NANOMEDICINE; NANOPHARMACEUTICS; NONHUMAN;

EID: 84961618744     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.07.007     Document Type: Article

References (119)

1. H.J. Federoff Novel targets for CNS gene therapy Gene Ther. 6 1999 1907 1908
2. W.M. Pardridge Why is the global CNS pharmaceutical market so under-penetrated? Drug Discov. Today 7 2002 5 7
3. N. Weiss, F. Miller, S. Cazaubon, and P.O. Couraud The blood-brain barrier in brain homeostasis and neurological diseases Biochim. Biophys. Acta 1788 2009 842 857
4. G. Tosi, L. Costantino, B. Ruozi, F. Forni, and M.A. Vandelli Polymeric nanoparticles for the drug delivery to the central nervous system Expert Opin. Drug Deliv. 5 2008 155 217
5. T.M. Barchet, and M.M. Amiji Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases Expert Opin. Drug Deliv. 6 2009 211 225
6. L. Costantino, G. Tosi, B. Ruozi, L. Bondioli, M.A. Vandelli, and F. Forni Colloidal systems for CNS drug delivery Prog. Brain Res. 180 2009 35 69
7. L. Montenegro, A. Campisi, M.G. Sarpietro, C. Carbone, R. Acquaviva, G. Raciti, and G. Puglisi In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain Drug Dev. Ind. Pharm. 37 2011 737 746
8. T. Musumeci, C.A. Ventura, C. Carbone, R. Pignatello, and G. Puglisi Effects of external phase on D-cycloserine loaded W/O nanocapsules prepared by the interfacial polymerization method Eur. J. Med. Chem. 46 2011 2828 2834
9. C. Puglia, G. Frasca, T. Musumeci, L. Rizza, G. Puglisi, F. Bonina, and S. Chiechio Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice Eur. J. Pharm. Biopharm. 81 2012 288 293
10. C. Carbone, B. Tomasello, B. Ruozi, M. Renis, and G. Puglisi Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design Eur. J. Med. Chem. 49 2012 110 117
11. L. Montenegro, A. Trapani, A. Latrofa, and G. Puglisi In vitro evaluation on a model of blood brain barrier of idebenone-loaded solid lipid nanoparticles J. Nanosci. Nanotechnol. 12 2012 330 337
12. R. Pignatello, A. Leonardi, R. Pellitteri, C. Carbone, S. Caggia, A.C.E. Graziano, and V. Cardile Evaluation of new amphiphilic PEG derivatives for preparing stealth lipid nanoparticles Coll. Surf. A - Physicochem. Eng. Asp. 434 2013 136 144
13. R. Pignatello, V. Pantò, G. Impallomeni, G.M. Carnemolla, C. Carbone, and G. Puglisi New amphiphilic conjugates of Amino-Poly(ethylene glycols) with lipoamino acids as surface modifiers of colloidal drug carriers Macromol. Chem. Phys. 214 2013 46 55
14. S. Trombino, R. Cassano, T. Ferrarelli, E. Barone, N. Picci, and C. Mancuso Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes Coll. Surf. B Biointerfaces 109 2013 273 279
15. P. Blasi, A. Schoubben, G.V. Romano, S. Biogagnoli, A. Di Michele, and M. Ricci Lipid nanoparticles for brin targeting II. Technological characterization Coll. Surf. B 110 2013 130 137
16. P. Blasi, A. Schoubben, G. Traina, G. Manfroni, L. Barberini, P.F. Alberti, C. Cirotto, and M. Ricci Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity Int. J. Pharm. 454 2013 316 323
17. C. Carbone, A. Campisi, T. Musumeci, G. Raciti, R. Bonfanti, and G. Puglisi FA-loaded lipid drug delivery systems: preparation, characterization and biological studies Eur. J. Pharm. Sci. 52 2014 12 20
18. T. Musumeci, R. Pellitteri, M. Spatuzza, and G. Puglisi Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake J. Pharm. Sci. 103 2014 628 635
19. C. Carbone, A. Campisi, D. Manno, A. Serra, M. Spatuzza, T. Musumeci, R. Bonfanti, and G. Puglisi The critical role of didodecyldimethylammonium bromide on physico-chemical, technological and biological properties of NLC Coll. Surf. B Biointerfaces 121 2014 1 10
20. R.N. Alyautidin, D. Gother, and V. Petrov Analgesic activity of the hexapeptide dalagrin adsorbed on the surface of polysorbate-80 coated polybutylcyanoacrylate nanoparticles Eur. J. Pharm. Biopharm. 41 1995 44 48
21. B. Ruozi, D. Belletti, F. Pederzoli, P. Veratti, F. Forni, M.A. Vandelli, and G. Tosi Nanotechnology and Alzheimer's disease: what has been done and what to do Curr. Med. Chem. 21 2014 4169 4185
22. G. Tosi, B. Ruozi, and D. Belletti Nanomedicine: the future for advancing medicine and neuroscience Nanomedicine 7 2012 1113 1116
23. J. Panyam, and V. Labhasetwar Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles Mol. Pharm. 1 2004 77 84
24. G.M. Dubowchik, and M.A. Walker Receptor-mediated and enzyme- dependent targeting of cytotoxic anticancer drugs Pharm. Ther. 83 1999 67 123
25. R. Savic, L. Luo, A. Eisenberg, and D. Maysinger Micellar nanocontainers distribute to defined cytoplasmic organelles Science 300 2003 615 618
26. F. Cengelli, D. Maysinger, F. Tschudi-Monnet, X. Montet, C. Corot, A. Petri-Fink, H. Hofmann, and L. Juillerat-Jeanneret Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures J. Pharm. Exp. Ther. 318 2006 108 116
27. N. Shi, and W.M. Pardridge Noninvasive gene targeting to the brain Proc. Natl. Acad. Sci. U. S. A. 97 2000 7567 7572
28. P.R. Lockman, R.J. Mumper, and M.A. Khan D.D. Allen Nanoparticle technology for drug delivery across the blood-brain barrier Drug Dev. Ind. Pharm. 28 2002 1 13
29. J. Kreuter Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain J. Nanosci. Nanotechnol. 4 2004 484 488
30. B. Ji, J. Maeda, M. Higuchi, K. Inoue, H. Akita, H. Harashima, and T. Suhara Pharmacokinetics and brain uptake of lactoferrin in rats Life Sci. 78 2006 851 855
31. J.M. Scherrmann, and J. Temsamani The use of Pep: trans vectors for the delivery of drugs into the central nervous system Int. Congr. Ser. 1277 2005 199 211
32. R. Gabathuler, G. Arthur, M. Kennard, Q. Chen, S. Tsai, J. Yang, W. Schoorl, T.Z. Vitalis, and W.A. Jefferies Development of a potential protein vector (NeuroTrans) to deliver drugs across the blood brain barrier Int. Congr. Ser. 1277 2005 171 184
33. C. Chakraborty, B. Sarkar, C.H.Z.H. Hsu Wen, C.S. Lin, and P.C. Shieh Future prospects of nanoparticles on brain targeted drug delivery J. Neurooncol. 93 2009 285 286
34. F. Umezawa, and Y. Eto Liposomes targeting to mouse brain: mannose as a recognition marker Biochem. Biophys. Res. Comm. 153 1988 1038 1044
35. W.M. Pardridge Drug and gene targeting to the brain with molecular Trojan horses Nat. Rev. Drug. Discov. 1 2002 131 139
36. R. Gabathuler Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiol. Dis. 37 2010 48 57
37. T. Moos, and E.H. Morgan Transferrin and transferring receptor function in brain barrier systems Cell. Mol. Neurobiol. 20 2001 77 95
38. S. Gosk, C. Vermehren, G. Storm, and T. Moos Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion J. Cer. Blood Flow. Met. 24 2004 1193 1204
39. P. Blasi, S. Giovagnoli, A. Schoubben, C. Puglia, F. Bonina, C. Rossi, and M. Ricci Lipid nanoparticles for brain targeting I. Formulation optimization Int. J. Pharm. 479 2011 287 295
40. N. Denora, V. Laquintana, A. Lopedota, M. Serra, L. Dazzi, G. Biggio, D. Pal, K. Mitra, A. Latrofa, G. Trapani, and G. Liso Novel L-Dopa and dopamine prodrugs containing a 2-Phenyl-imidazopyridine moiety Pharm. Res. 24 2007 1309 1324
41. D. Chirio, M. Gallarate, E. Peira, L. Battaglia, E. Muntoni, C. Riganti, E. Biasibetti, M.T. Capucchio, A. Valazza, P. Panciani, M. Lanotte, L. Annovazzi, V. Caldera, M. Mellai, G. Filice, S. Corona, and D. Schiffer Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment Eur. J. Pharm. Biopharm. 88 2014 746 758
42. L. Battaglia, M. Gallarate, E. Peira, D. Chirio, E. Muntoni, E. Biasibetti, M.T. Capucchio, A. Valazza, P.P. Panciani, M. Lanotte, D. Schiffer, L. Annovazzi, V. Caldera, M. Mellai, and C. Riganti Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies J. Pharm. Sci. 103 2014 2157 2165
43. A.M. Grabrucker, C.C. Garner, T.M. Boeckers, L. Bondioli, B. Ruozi, F. Forni, M.A. Vandelli, and G. Tosi Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences PLoS One 6 2011 e17851
44. G. Tosi, A. Vilella, R. Chhabra, M.J. Schmeisser, T.M. Boeckers, B. Ruozi, M.A. Vandelli, F. Forni, M. Zoli, and A.M. Grabrucker Insight on the fate of CNS-targeted nanoparticles. Part II: intercellular neuronal cell-to-cell transport J. Control. Rel 177 2014 96 107
45. A. Vilella, G. Tosi, A.M. Grabrucker, B. Ruozi, D. Belletti, M.A. Vandelli, T.M. Boeckers, F. Forni, and M. Zoli Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution J. Control. Rel 174 2014 195 201
46. R. Chhabra, A.M. Grabrucker, P. Veratti, D. Belletti, T.M. Boeckers, M.A. Vandelli, F. Forni, G. Tosi, and B. Ruozi Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release Int. J. Pharm. 471 2014 349 357
47. B. Tancini, G. Tosi, B. Bortot, D. Dolcetta, A. Magini, E. De Martino, L. Urbanelli, B. Ruozi, F. Forni, C. Emiliani, M.A. Vandelli, and G.M. Severini Use of polylactide-co-glycolide-nanoparticles for lysosomal delivery of a therapeutic enzyme in Glycogenosis Type II Fibroblasts J. Nanosci. Nanotechnol. 15 2015 2657 2666
48. F. Re, I. Cambianica, C. Zona, S. Sesana, M. Gregori, R. Rigolio, B. La Ferla, F. Nicotra, G. Forloni, A. Cagnotto, M. Salmona, M. Masserini, and G. Sancini Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drugtransport across a blood-brain barrier model Nanomedicine 7 2011 551 559
49. L. Bana, S. Minniti, E. Salvati, S. Sesana, V. Zambelli, A. Cagnotto, A. Orlando, E. Cazzaniga, R. Zwart, W. Scheper, M. Masserini, and F. Re Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease Nanomedicine 10 2013 1583 1590
50. E. Salvati, F. Re, S. Sesana, I. Cambianica, G. Sancini, M. Masserini, and M. Gregori Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model Int. J. Nanomed. 8 2013 1749 1758
51. M. Canovi, E. Markoutsa, A.N. Lazar, G. Pampalakis, C. Clemente, F. Re, S. Sesana, M. Masserini, M. Salmona, C. Duyckaerts, O. Flores, M. Gobbi, and S.G. Antimisiaris The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue Biomaterials 32 2011 5489 5497
52. Y. Takasato, S.I. Rapoport, and Q.R. Smith An in situ brain perfusion technique to study cerebrovascular transport in the rat Am. J. Physiol. 247 1984 H484 H493
53. J.M. Koziara, P.R. Lockman, D.D. Allen, and R.J. Mumper In situ blood-brain barrier transport of nanoparticles Pharm. Res. 20 2003 1772 1778
54. P.R. Lockman, J. Koziara, K.E. Roder, J. Paulson, T.J. Abbruscato, R.J. Mumper, and D.D. Allen In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles Pharm. Res. 20 2003 705 713
55. P.R. Lockman, M.O. Oyewumi, J.M. Koziara, K.E. Roder, R.J. Mumper, and D.D. Allen Brain uptake of thiamine-coated nanoparticles J. Control Release 93 2003 271 282
56. D.D. Allen, J. Oki, and Q.R. Smith An update on the in situ brain perfusion technique: simple, faster, better Pharm. Res. 14 1997 337
57. J.M. Koziara, P.R. Lockman, D.D. Allen, and R.J. Mumper Paclitaxel nanoparticles for the potential treatment of brain tumors J. Control. Release 30 2004 259 269
58. A. Zensi, D. Begley, C. Pontikis, C. Legros, L. Mihoreanu, S. Wagner, S.,C. Büchel, H. von Briesen, and J. Kreuter Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurons J. Control. Release 137 2009 78 86
59. J.P. Calvo, B. Gouritin, H. Chacun, D. Desmaële, J. D'Angelo, J.P. Noel, D. Georgin, E. Fattal, J.P. Andreux, and P. Couvreur Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery Pharm. Res. 18 2001 1157 1166
60. A. Ambruosi, S. Gelperina, A. Khalansky, S. Tanski, A. Theisen, and J. Kreuter Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model J. Microencapsul. 23 2006 582 592
61. U. Schroeder, H. Schroeder, and B.A. Sabel Body distribution of 3H-labelled dalargin bound to poly(butylcyanoacrylate) nanoparticles after their i.v. injection in mice Life Sci. 66 2000 495 502
62. O. Veiseh, C. Sun, C. Fang, N. Bhattarai, J. Gunn, F. Kievit, K. Du, B. Pullar, D. Lee, R.G. Ellenbogen, J. Olson, and M. Zhang Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier Cancer Res. 69 2009 6200 6207
63. E.K. Agyare, G.L. Curran, M. Ramakrishnan, C.C. Yu, J.F. Poduslo, and K.K. Kandimalla Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy Pharm. Res. 25 2008 2674 2684
64. A. Yesim, M. Yemisci, K. Andrieux, R.N. Gürsoy, M.J. Alonso, E. Fernandez-Megia, R. Novoa-Carballal, E. Quiñoá, R. Riguera, M.F. Sargon, H.H. Celik, A.S. Demir, A.A. Hincal, T. Dalkara, Y. Capan, and P. Couvreur Development and brain delivery of chitosan-PEG nanoparticles functionalized with monoclonal antibody OX26 Bioconjug. Chem. 16 2005 1503 1511
65. Y. Monsalve, G. Tosi, B. Ruozi, D. Belletti, A. Vilella, M. Zoli, M.A. Vandelli, F. Forni, B.L. López, and L. Sierra Poly(ethylene glycol)-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting Nanomedicine 10 2015 1735 1750
66. W. Sun, C. Xie, H. Wang, and Y. Hu Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain Biomaterials 25 2004 3065 3071
67. A.E. Gulyaev, S.E. Gelperina, I.N. Skidan, A.S. Antropov, G.Y. Kivman, and J. Kreuter Significant transport of Doxorubicin into the brain with polysorbate 80-coated nanoparticles Pharm. Res. 16 1999 1564 1569
68. B. Wilson, M.K. Samanta, K. Santhi, K.P.S. Kumar, N. Paramakrishnan, and B. Suresh Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease Brain Res. 1200 2008 159 168
69. B. Wilson, M.K. Samanta, K. Santhi, K.P.S. Kumar, N. Paramakrishnan, and B. Suresh Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles Eur. J. Pharm. Biopharm. 70 2008 75 84
70. B. Feng, K. Tomizawa, H. Michiue, S. Miyatake, X.J. Han, A. Fujimura, M. Seno, M. Kirihata, and H. Matsui Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His Biomaterials 30 2009 1746 1755
71. J. Huwyler, D. Wu, and W.M. Pardridge Brain drug delivery of small molecules using immunoliposomes Proc. Natl. Acad. Sci. U. S. A. 93 1996 14164 14169
72. J. Huwyler, J. Yan, and W.M. Pardridge Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat J. Pharm. Exp. Ther. 282 1997 1541 1546
73. A. Schnyder, S. Krähenbühl, J. Drewe, and J. Huwyler Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects J. Drug Targ. 13 2005 325 335
74. M.L. Bondì, E.F. Craparo, G. Giammona, and F. Drago Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution Nanomedicine 5 2010 25 32
75. J. Kreuter, V.E. Petrov, D.A. Kharkevich, and R.N. Alyautdin Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles J. Control. Rel 49 1997 81 87
76. J. Kreuter, P. Ramge, V. Petrov, S. Hamm, S.E. Gelperina, B. Engelhardt, R. Alyautdin, H. von Briesen, and D.J. Begley Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles Pharm. Res. 20 2003 409 416
77. J. Kreuter, D. Shamenkov, V. Petrov, P. Ramge, K. Cychutek, C. Koch-Brandt, and R. Alyautdin Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier J. Drug Target. 10 2002 317 325
78. R.N. Alyautdin, V.E. Petrov, K. Langer, A. Berthold, D.A. Kharkevich, and J. Kreuter Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles Pharm. Res. 14 1997 325 328
79. W. Lu, Y. Zhang, Y.Z. Tan, K.L. Hu, X.G. Jiang, and S.K. Fu Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery J. Control. Release 107 2005 428 448
80. W. Lu, Q. Sun, J. Wan, Z. She, and X.G. Jiang Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration Cancer Res. 66 2006 11878 11887
81. W. Lu, J. Wan, Z. She, and X. Jiang Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle J. Control. Release 118 2007 38 53
82. L. Costantino, F. Gandolfi, G. Tosi, F. Rivasi, M.A. Vandelli, and F. Forni Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier J. Control. Release 108 2005 84 96
83. G. Tosi, L. Costantino, B. Ruozi, F. Forni, and M.A. Vandelli Polymeric nanoparticles for the drug delivery to the central nervous system Exp. Opin. Drug Deliv. 5 2008 155 174
84. G. Tosi, B. Ruozi, D. Belletti, A. Vilella, M. Zoli, M.A. Vandelli, and F. Forni Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents Nanomedicine 8 2013 1373 1383
85. A.V. Vergoni, G. Tosi, R. Tacchi, M.A. Vandelli, A. Bertolini, and L. Costantino Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution Nanomedicine NBM 5 2009 369 377
86. N. Shi, R.J. Boado, and W.M. Pardridge Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes Pharm. Res. 18 2001 1091 1095
87. N. Shi, Y. Zhang, C. Zhu, R.J. Boado, and W.M. Pardridge Brain specific expression of an exogenous gene after i.v. administration Proc. Natl. Acad. Sci. 98 2001 12754 12759
88. S. Liebner, A. Fischmann, G. Rascher, F. Duffner, E.H. Grote, H. Kalbacher, and H. Wolburg Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme Acta Neuropathol. 100 2000 323 331
89. Y. Zhang, F. Schlachetzki, J.Y. Li, R.J. Boado, and W.M. Pardridge Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer Mol. Vis. 9 2003 465 472
90. M. Iannone, D. Cosco, F. Cilurzo, C. Celia, D. Paolino, V. Mollace, D. Rotiroti, and M. Fresta A novel animal model to evaluate the ability of a drug delivery system to promote the passage through the BBB Neurosci. Lett. 469 2010 93 96
91. E. Esposito, M. Fantin, M. Drechsler, L. Paccamiccio, P. Mariani, E. Sivieri, F. Lain, E. Menegatti, M. Morari, and R. Cortesi Solid lipid nanoparticles as delivery systems for bromocriptine Pharm. Res. 25 2008 1521 1530
92. E. Esposito, P. Mariani, L. Ravani, C. Contado, M. Volta, S. Bido, M. Drechsler, S. Mazzoni, E. Menegatti, M. Morari, and R. Cortesi Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study Eur. J. Pharm. Biopharm. 80 2012 306 314
93. A. Trapani, E. De Giglio, D. Cafagna, N. Denora, G. Agrimi, T. Cassano, S. Gaetani, V. Cuomo, and G. Trapani Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery Int. J. Pharm. 419 2011 296 307
94. P. Blasi, A. Schoubben, G. Traina, G. Manfroni, L. Barberini, P.F. Alberti, C. Cirotto, and M. Ricci Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity Int. J. Pharm. 454 2013 316 323
95. A. Doi, S. Kawabata, K. Ida, K. Yokoyama, Y. Kajimoto, T. Kuroiwa, T. Shirakawa, M. Kirihata, S. Kasaoka, K. Maruyama, H. Kumada, Y. Sakurai, S.-I. Masunaga, K. Ono, and S.I. Miyatake Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy J. Neurooncol. 87 2008 287 294
96. S. Brem, R. Cotran, and J. Folkman Tumor angiogenesis: a quantitative method for histologic grading J. Int. Cancer Inst. 48 1972 347 356
97. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, C.R. Janzer, K.S.L.T. Gorlia, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, and R.O. Mirimanoff Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma New Engl. J. Med. 352 2005 987 996
98. S.C. Steiniger, J. Kreuter, A.S. Khalansky, I.N. Skidan, A.I. Bobruskin, Z.S. Smirnova, S.E. Severin, R. Uhl, M. Kock, K.D. Geiger, and S.E. Gelperina Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles Int. J. Cancer 109 2004 759 767
99. C. Dai, and E.C. Holland Glioma models Biochim. Biophys. Acta Cancer 1551 2001 19 27
100. P. Vajkoczy, and M.D. Menger Vascular microenvironment in gliomas J. Neurooncol. 50 2001 99 108
101. M.G. Donelli, M. Zucchetti, and M. D'Incalci Do anticancer agents reach the tumor target in the human brain? Cancer Chemother. Pharmacol. 30 1992 251 260
102. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J. Am. Stat. Ass 53 1958 457 481
103. P. Ballabh, A. Braun, and M. Nedergaard The blood-brain barrier: an overview, structure, regulation, and clinical implications Neurobiol. Dis. 16 2004 1 13
104. T. Siegal, A. Horowitz, and A. Gabizon Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy J. Neurosurg. 83 1995 1029 1037
105. U.S. Sharma, A. Sharma, R.I. Chau, and M. Straubinger Liposome-mediated therapy of intracranial brain tumors in a rat model Pharm. Res. 8 1997 992 998
106. I. Brigger, J. Morizet, L. Laudani, G. Aubert, M. Appel, V. Velasco, M.J. Terrier-Lacombe, D. Desmaële, J. d'Angelo, P. Couvreur, and G. Vassal Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model J. Control. Release 100 2004 29 40
107. R. Zhou, R.V. Mazurchuk, J.H. Tamburlin, J.M. Harrold, D.E. Mager, and R.M. Straubinger Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model J. Pharm. Exp. Ther. 332 2010 479 488
108. R. Abounader, B. Lal, C. Luddy, G. Koe, B. Davidson, E.M. Rosen, and J. Laterra In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis FASEB J. 16 2002 108 110
109. R.J. Higgins, M. McKisic, P.J. Dickinson, D.F. Jimenez, S.W. Dow, L.D. Tripp, and R.A. LeCouter Growth inhibition of an orthotopic glioblastoma in immunocompetent mice by cationic lipid-DNA complexes Cancer Immunol. Immunother. 53 2004 338 344
110. B. Petri, A. Bootz, A. Khalansky, T. Hekmatara, R. Müller, R. Uhl, R.,J. Kreuter, and S.E. Gelperina Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants J. Control. Release 117 2007 51 58
111. C.X. Wang, L.S. Huang, L.B. Hou, L. Jiang, Z.T. Yan, Y.L. Wang, and Z.-L. Chen Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model Brain Res. 1261 2009 91 99
112. S.E. Gelperina, O. Maksimenko, A. Khalansky, L. Vanchugova, E. Shipulo, K. Abbasova, R. Berdiev, S. Wohlfart, N. Chepurnova, and J. Kreuter Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters Eur. J. Pharm. Biopharm. 74 2010 157 163
113. A.B. Madhankumar, B. Slagle-Webb, X. Wang, Q.X. Yang, D.A. Antonetti, P.A. Miller, J.M. Sheehan, and J.R. Connor Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model Mol. Canc. Ther. 8 2009 649 654
114. L.S. Del Burgo, R.M. Hernández, G. Orive, and J.L. Pedraz Nanotherapeutic approaches for brain cancer management Nanomedicine 10 2014 905 919
115. J.D. Meyers, T. Doane, C. Burda, and J.P. Basilion Nanoparticles for imaging and treating brain cancer Nanomedicine 8 2013 123 143
116. Y. Zhang, C. Zhu, and W.M. Pardridge Antisense gene therapy of brain cancer with an artificial virus gene delivery system Mol. Ther. 6 2002 67 72
117. J. Du, W.L. Lu, X. Ying, Y. Liu, P. Du, W. Tian, Y. Men, J. Guo, Y. Zhang, R.J. Li, J. Zhou, J.-N. Lou, J.-C. Wang, X. Zhang, and Q. Zhang Dual-targeting topotecan liposomes modified with Tamoxifen and Wheat Germ Agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals Mol. Pharm. 3 2009 905 917
118. X. Ying, H. Wen, W.L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.-Y. Yang, D.-W. Shang, J.-N. Lou, L.-R. Zhang, and Q. Zhang Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Control. Release 141 2010 183 192
119. H.E. de Vries, J. Kuiper, A.G. de Boer, T.J.C. Van Berkel, and D.D. Breime The blood-brain barrier in neuroinflammatory diseases Pharm. Rev. 49 1997 143 155